Haleon CEO says 70% of cold and flu business outside US, China Centrum OTC issue unlikely resolved in 2027

Haleon CEO says 70% of its cold and flu business is outside the US, with the season start not yet seen in international markets and slightly down to date. The CEO said the China Centrum OTC issue is not expected to have a solution in 2027, with the company working to mitigate by making portfolio changes in China, and said the company does not have a pricing issue.

Detected & updated continuously · Source: Nebula